Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021)

Insight Molecular Diagnostics (IMDX) has disclosed Tax Provisions for 2 consecutive years, with -$97000.0 as the latest value for Q4 2021.

  • Quarterly Tax Provisions fell 161.01% to -$97000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$97000.0 through Sep 2024, changed N/A year-over-year, with the annual reading at -$1.2 million for FY2022, 87.1% up from the prior year.
  • Tax Provisions hit -$97000.0 in Q4 2021 for Insight Molecular Diagnostics, up from -$1.8 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1.1 million in Q1 2020 to a low of -$7.6 million in Q1 2021.